American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
50.11
+0.14 (0.28%)
At close: Dec 5, 2025, 4:00 PM EST
50.90
+0.79 (1.58%)
After-hours: Dec 5, 2025, 7:57 PM EST
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for American Healthcare REIT stock ranges from a low of $37 to a high of $60. The average analyst price target of $51.8 forecasts a 3.37% increase in the stock price over the next year.
Price Target: $51.80 (+3.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $46 → $53 | Strong Buy | Maintains | $46 → $53 | +5.77% | Nov 26, 2025 |
| Citigroup | Citigroup | Hold Maintains $45 → $52 | Hold | Maintains | $45 → $52 | +3.77% | Nov 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $52 → $55 | Buy | Maintains | $52 → $55 | +9.76% | Nov 20, 2025 |
| UBS | UBS | Strong Buy Maintains $51 → $56 | Strong Buy | Maintains | $51 → $56 | +11.75% | Nov 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $55 | Buy | Maintains | $47 → $55 | +9.76% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
2.26B
from 2.06B
Increased by 9.41%
Revenue Next Year
2.47B
from 2.26B
Increased by 9.26%
EPS This Year
0.42
from -0.29
EPS Next Year
0.73
from 0.42
Increased by 73.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.4B | 2.8B | ||
| Avg | 2.3B | 2.5B | ||
| Low | 2.1B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 17.8% | 26.0% | ||
| Avg | 9.4% | 9.3% | ||
| Low | 3.7% | 0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.56 | 0.84 | |
| Avg | 0.42 | 0.73 | |
| Low | 0.30 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 99.2% | |
| Avg | - | 73.9% | |
| Low | - | 34.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.